ACTIMID

Details for Australian Trade Mark No. 899457 (hide)

Owner Celgene Corporation a Delaware corporation

Service Banki Haddock Fiora Lawyers Level **** Street SYDNEY NSW 2000 AUSTRALIA

Various Convention priority claimed: 19 December 2001, United States of America, in respect of, PHARMACEUTICAL PREPARATIONS, NAMELY CYTOKINE INHIBITORY DRUGS; PHARMACEUTICAL PREPARATIONS THAT MODULATE THE IMMUNE SYSTEM.*

Classes

Class 5 Pharmaceutical preparations, including cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system

Event Publications

8 September 2011 Renewal of Registration/IR

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

899460-Marliflex

899456-REEL ACTION